Pieter Sonneveld, MD, PhD, explained how sustained MRD negativity with DVRd in the PERSEUS trial may guide long-term outcome counseling in multiple myeloma.
Pieter Sonneveld, MD, PhD
Advertisement
Articles by Pieter Sonneveld, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Belzutifan Combo Receives FDA Approval in Advanced Clear Cell RCC
2
MELT-MM Regimen Yields Responses in Relapsed/Refractory Multiple Myeloma
3
Cevostamab Combo Shows Durable Responses in R/R Multiple Myeloma
4
SOHO-02 Trial Will Confirm Sevabertinib’s Frontline NSCLC Benefit
5